why choose us

First received: February 17, 2023

Clinical Trial: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants With Advanced Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Locally Advanced Unresectable or Metastatic Solid Tumor

Study Type: INTERVENTIONAL


Official Title: A Phase I First-in-human, Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants With Advanced Soli

Brief Summary: This is a multicenter, open-label, phase I study to evaluate the safety, efficacy, and pharmacokinetic (PK)/pharmacodynamic(PD) characteristics of SIM0237 in participants with advanced solid tumors.

Read more